← Back

$ Value

$0

Shares

69,360

Price

$0

Filed

Jan 27

Insider

Name

Reilly Joseph James

Title

See Remarks

CIK

0002044416

Roles

Officer

Transaction Details

Transaction Date

2026-01-23

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

69,360

Footnotes

Restricted stock units ("RSUs"). The Reporting Person is entitled to receive one (1) shares of Common Stock for each one (1) RSU upon the vesting thereof. | Includes the purchase of 1,667 shares under the Ardelyx Employee Stock Purchase Plan on August 31, 2025. | The option becomes exercisable as it vests and the shares subject to the option vest in 48 successive, equal monthly installments on each monthly anniversary of January 23, 2026, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.

Filing Info

Accession No.

0001610717-26-000028

Form Type

4

Issuer CIK

0001437402

Reilly Joseph James's History

Date Ticker Type Value
2026-02-20 ARDX $26K
2026-02-20 ARDX $3K
2026-02-20 ARDX $11
2026-01-23 ARDX A $0
2026-01-23 ARDX A $0
2025-11-21 ARDX $61K

Other Insiders at ARDX (90d)

Insider Bought Sold Last
MOTT DAVID M $1.9M 2026-02-20
Bishop John E
See Remarks
$19K 2026-02-20
RAAB MICHAEL
President & CEO
$791K 2026-04-15
Williams Laura A
Chief Patient Officer
2026-01-23
Williams Laura A
See Remarks
$48K 2026-02-20
Kelliher Mike
See Remarks
$56K 2026-02-20
Foster Eric Duane
Chief Commercial Officer
$61K 2026-02-20
Reilly Joseph James
See Remarks
$29K 2026-02-20
Brady James Parker
Chief Human Resources Officer
$15K 2026-02-20
Hohenleitner Susan
Chief Financial Officer
$12K 2026-02-20